Common questions about INF (FAQ)
Q: Do I need to change my diet while taking INF?
Official product information advises patients to avoid the consumption of alcohol while using this product. This caution is advised because combining INF with alcohol may increase the risk of liver injury. No other general dietary modifications are specifically defined in the regulatory documents.
Q: Is it common to feel different right after starting INF?
Yes, some people experience reactions during or shortly after the infusion, known as infusion reactions. These reactions are usually monitored by a healthcare professional in the clinic and may include symptoms such as fever, chills, itching, chest pain, or changes in blood pressure. The official label notes these as potential side effects.
Q: Can INF cause problems if I have a pre-existing liver condition?
Official documentation notes that liver problems, including rare but serious cases of liver damage and the reactivation of Hepatitis B, have been reported with INF. For this reason, official guidance states that patients should be assessed for underlying liver conditions, including Hepatitis B infection, before beginning treatment and monitored during therapy.
Q: Does INF have a warning about driving or operating machinery?
Caution is generally advised regarding driving or operating machinery following an infusion of INF. Official documents note that some temporary effects, such as dizziness or changes in vision, have been reported after administration.
Q: Is INF safe to take with common over-the-counter pain relievers?
The official product label details known drug interactions involving certain liver enzymes and medicines that affect blood cell counts or the central nervous system. Specific warnings regarding common, non-prescription pain relievers are not defined, but questions regarding non-prescription pain relievers can be reviewed with a healthcare professional.
Q: Can INF cause changes in mood or sleep?
The official label reports cases of neurologic reactions and states that combining INF with certain central nervous system (CNS) active drugs increases the risk of side effects. While mood or sleep changes are not specifically called out as common effects of INF alone, it is appropriate to discuss any unusual changes with a healthcare professional.
Q: Is INF addictive?
No. INF is classified as an antibody that works by targeting the inflammatory protein TNF- alpha. It is not an opioid, depressant, or stimulant, and no regulatory warnings classify it as having addictive potential.
Q: Does the effectiveness of INF wear off over time?
Regulatory documents describe a phenomenon called 'loss of response' in some patients who have been using the medication for a period of time. The official prescribing information notes that physicians may consider adjusting the dosage or the interval between infusions for patients who experience this.
Q: What happens if a person who is pregnant uses INF?
Official guidance notes that INF is known to cross the placenta, mainly during the late second and third trimesters. For infants exposed to INF in the womb, official recommendations advise that live vaccines should be postponed until the infant's serum levels of the medication are undetectable, which may take up to six months after birth.
Q: Is INF safe for people with kidney problems?
Regulatory documentation indicates that INF has not been specifically studied in patients with kidney impairment. Because of this, no specific dosing recommendations for this population can be made based on the current official product data.
Q: Will I need regular blood tests while on INF?
Yes. Official documentation advises mandatory testing for conditions like latent tuberculosis and Hepatitis B virus (HBV) before treatment begins. Ongoing monitoring for the reactivation of HBV and for hematologic reactions (low blood cell counts), which typically involve blood testing, is also recommended.
Q: Does INF interact with common cold or allergy medications?
The official label notes interactions with medicines that affect the Central Nervous System (CNS). Because some cold and allergy medications contain components that affect the CNS, questions about all medications, including over-the-counter products, can be reviewed with a healthcare professional.
Q: What should I tell my dentist before a procedure if I am taking INF?
The regulatory profile highlights an increased risk of serious infections. Sharing information about all medications with a healthcare provider is a standard step before medical procedures, particularly those that carry a risk of infection.
Q: What is the difference between the generic and brand name versions of INF?
INF is a type of medicine known as a biologic (an antibody). It is available as the original brand-name product and through highly similar versions called biosimilars. Biosimilars are approved based on evidence that they have no clinically meaningful differences in terms of safety and effectiveness from the original brand product.
Q: Does INF require a special prescription or monitoring program?
INF is an intravenous prescription medication administered only by a healthcare professional in a clinical setting and requires monitoring for infusion reactions. Official documents require mandatory screening for certain infections, like TB and Hepatitis B, before treatment begins.
Q: How long does INF stay in your system after stopping it?
The median terminal half-life of INF is approximately 7.7 to 9.5 days. This means that it can take several weeks for the medication to be substantially cleared from the body.
Q: Are there certain activities or environments to avoid while taking INF?
Official information advises patients to avoid live vaccines during treatment with INF. Additionally, reports of rash occurring on sun-exposed areas of the body suggest caution is needed with prolonged or intense sun exposure.
Q: Is it true that INF can cause [specific, common online rumor]? (e.g., hair loss)
Official reports indicate that hair loss (alopecia) has been reported in post-marketing surveillance for this product. Changes such as hair loss can be discussed with a healthcare professional for evaluation, as the cause may be complex, potentially relating to the medication or the underlying inflammatory condition being treated.
Q: Can INF be used by people with autoimmune conditions?
Yes. INF is approved for use in several conditions that are classified as autoimmune and inflammatory diseases, such as Rheumatoid Arthritis and Ulcerative Colitis. Its purpose is to modulate and dampen the immune system's inflammatory response.
Q: What should I do if I think I have an interaction with INF?
Official patient information notes that if a patient develops any unusual symptoms or signs that may suggest a serious reaction or interaction, it is appropriate to contact their prescribing physician.
Q: Are there variations in how INF works for different people?
Yes. The official dosing schedule includes provisions for patients who experience a 'loss of response' to the standard dose over time. This indicates that individual responses to the treatment can vary.
Q: Is it possible to be allergic to INF?
Yes. The official warnings and precautions section reports that severe hypersensitivity reactions, including anaphylaxis, have been reported with INF. A previous severe reaction to the product is listed as a contraindication (a reason the drug should not be used).
Q: What kind of research has been done on INF?
The clinical trials used to support the approval of INF have included a variety of study designs. This research typically includes randomized, controlled studies for conditions like Crohn's disease and rheumatoid arthritis, along with other types of research for specific patient populations.
Q: Are there any published studies that compare INF to placebo?
Yes. The clinical study sections in the regulatory documents for the approved indications (such as Crohn's Disease and Rheumatoid Arthritis) describe trials that included placebo groups to compare the effects of INF.
Q: Is INF a biologic drug?
Yes. INF is classified as a biologic medicine. Specifically, it is a chimeric monoclonal antibody, which is a complex molecule produced using living cells that is designed to target the TNF- alpha protein.
Q: Why is it important to keep using INF even if I feel better?
INF is approved for inducing a response and then for the long-term maintenance of that response in many inflammatory conditions. The dosing schedules are designed to sustain the therapeutic effect, indicating its importance beyond the initial phase of feeling better.
Q: Are there any patient assistance programs for INF?
Information regarding patient access and affordability is available. Resources such as patient assistance programs are often available to help people access their medication.
